Cargando…
Bacteriophages: Protagonists of a Post-Antibiotic Era
Despite their long success for more than half a century, antibiotics are currently under the spotlight due to the emergence of multidrug-resistant bacteria. The development of new alternative treatments is of particular interest in the fight against bacterial resistance. Bacteriophages (phages) are...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163168/ https://www.ncbi.nlm.nih.gov/pubmed/30060506 http://dx.doi.org/10.3390/antibiotics7030066 |
_version_ | 1783359295933382656 |
---|---|
author | Domingo-Calap, Pilar Delgado-Martínez, Jennifer |
author_facet | Domingo-Calap, Pilar Delgado-Martínez, Jennifer |
author_sort | Domingo-Calap, Pilar |
collection | PubMed |
description | Despite their long success for more than half a century, antibiotics are currently under the spotlight due to the emergence of multidrug-resistant bacteria. The development of new alternative treatments is of particular interest in the fight against bacterial resistance. Bacteriophages (phages) are natural killers of bacteria and are an excellent tool due to their specificity and ecological safety. Here, we highlight some of their advantages and drawbacks as potential therapeutic agents. Interestingly, phages are not only attractive from a clinical point of view, but other areas, such as agriculture, food control, or industry, are also areas for their potential application. Therefore, we propose phages as a real alternative to current antibiotics. |
format | Online Article Text |
id | pubmed-6163168 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-61631682018-10-12 Bacteriophages: Protagonists of a Post-Antibiotic Era Domingo-Calap, Pilar Delgado-Martínez, Jennifer Antibiotics (Basel) Review Despite their long success for more than half a century, antibiotics are currently under the spotlight due to the emergence of multidrug-resistant bacteria. The development of new alternative treatments is of particular interest in the fight against bacterial resistance. Bacteriophages (phages) are natural killers of bacteria and are an excellent tool due to their specificity and ecological safety. Here, we highlight some of their advantages and drawbacks as potential therapeutic agents. Interestingly, phages are not only attractive from a clinical point of view, but other areas, such as agriculture, food control, or industry, are also areas for their potential application. Therefore, we propose phages as a real alternative to current antibiotics. MDPI 2018-07-27 /pmc/articles/PMC6163168/ /pubmed/30060506 http://dx.doi.org/10.3390/antibiotics7030066 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Domingo-Calap, Pilar Delgado-Martínez, Jennifer Bacteriophages: Protagonists of a Post-Antibiotic Era |
title | Bacteriophages: Protagonists of a Post-Antibiotic Era |
title_full | Bacteriophages: Protagonists of a Post-Antibiotic Era |
title_fullStr | Bacteriophages: Protagonists of a Post-Antibiotic Era |
title_full_unstemmed | Bacteriophages: Protagonists of a Post-Antibiotic Era |
title_short | Bacteriophages: Protagonists of a Post-Antibiotic Era |
title_sort | bacteriophages: protagonists of a post-antibiotic era |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163168/ https://www.ncbi.nlm.nih.gov/pubmed/30060506 http://dx.doi.org/10.3390/antibiotics7030066 |
work_keys_str_mv | AT domingocalappilar bacteriophagesprotagonistsofapostantibioticera AT delgadomartinezjennifer bacteriophagesprotagonistsofapostantibioticera |